• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION SD ALARIS SYSTEM; PUMP, INFUSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION SD ALARIS SYSTEM; PUMP, INFUSION Back to Search Results
Model Number 8120
Device Problems Contamination (1120); Excess Flow or Over-Infusion (1311); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Low Oxygen Saturation (2477)
Event Date 06/29/2022
Event Type  Death  
Manufacturer Narrative
A follow up report will be submitted once the failure investigation has been completed.Per 803.52(f)(11)(iii) the information provided represents all of the known information at this time.The complainant or reporter was unable or unwilling to provide any further patient, product, or procedural details to the manufacturer.
 
Event Description
It was reported that a patient, who was in the emergency department (ed) receiving hydromorphone 0.4mg/ml at a rate of 0.3 mg/hr and volume to be infused of 25ml via pca pump, was transferred to another facility.The patient transfer reportedly occurred while pca infusion was ongoing.The hospital's pharmacist downloaded the infusion report and noted that they "could not get any data from when the patient was at the receiving facility." once "back" to the original facility, the pharmacist was able to download the infusion data for "the whole time period." there was reportedly "a 50 minute window starting at 1631 of missing infusion data" where pca "alarmed syringe empty." per customer, no other infusion data was available until 1723 while the patient was in high dose therapy mode and a pca max limit alarmed when the maximum 12mg of medication was infused.Subsequently, the patient's oxygen level desaturated in the low 80's.A rapid response was called and narcan 0.2mg was given.The patient reportedly "initially improved but later deteriorated and passed away" two days after the event date.According to the hospital's medication safety officer, it is not believed that the device may have caused or contributed to the death.However, they mentioned that they have "not completely ruled it out until i can inspect the keystroke data against the all infusion data.".
 
Manufacturer Narrative
Omit : b21 - type of investigation not yet determined, c21 - results pending completion of investigation, d16 - conclusion not yet available.Correction : medical device type.Additional information : device eval by manufacturer?, reason code for no evaluation, if other specify, imdrf annex a, b, c, d, g codes and manufacturer narrative.A device history record review is performed on each device reported in a mdr reportable event along with other methods of investigation as coded in section h6 of this mdr report.H3 other text : not applicable.Device evaluated by bd.
 
Event Description
It was reported that a patient, who was in the emergency department (ed) receiving hydromorphone 0.4mg/ml at a rate of 0.3 mg/hr and volume to be infused of 25ml via pca pump, was transferred to another facility.The patient transfer reportedly occurred while pca infusion was ongoing.The hospital's pharmacist downloaded the infusion report and noted that they "could not get any data from when the patient was at the receiving facility." once "back" to the original facility, the pharmacist was able to download the infusion data for "the whole time period." there was reportedly "a 50 minute window starting at 1631 of missing infusion data" where pca "alarmed syringe empty." per customer, no other infusion data was available until 1723 while the patient was in high dose therapy mode and a pca max limit alarmed when the maximum 12mg of medication was infused.Subsequently, the patient's oxygen level desaturated in the low 80's.A rapid response was called and narcan 0.2mg was given.The patient reportedly "initially improved but later deteriorated and passed away" two days after the event date.According to the hospital's medication safety officer, it is not believed that the device may have caused or contributed to the death.However, they mentioned that they have "not completely ruled it out until i can inspect the keystroke data against the all infusion data.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS SYSTEM
Type of Device
PUMP, INFUSION
Manufacturer (Section D)
CAREFUSION SD
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer Contact
brett wilko
10020 pacific mesa blvd
san diego, CA 92121-4386
8586172000
MDR Report Key15119371
MDR Text Key296747192
Report Number2016493-2022-167348
Device Sequence Number1
Product Code MEA
UDI-Device Identifier10885403812002
UDI-Public(01)10885403812002
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K043299
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/28/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number8120
Device Catalogue Number8120 ALARIS PCA MODULE
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/25/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/06/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/14/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
8015
Patient Outcome(s) Death;
Patient Age34 YR
Patient SexMale
Patient Weight105 KG
-
-